U.S. Patents Awarded to Inventors in California (Jan. 5)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Jan. 5 -- The following federal patents were awarded to inventors in California.

*** Ardea Biosciences Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Ardea Biosciences, San Diego, has been assigned a patent (8,344,012) developed by Esmir Gunic, San Diego, Jean-Luc Girardet, San Diego, and David A. Paisner, Encinitas, Calif., for "compounds, compositions and methods of using same for modulating uric acid levels." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid." The patent application was filed on Sept. 4, 2009 (12/554,737). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,012&OS=8,344,012&RS=8,344,012 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Designer Molecules Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Designer Molecules, San Diego, has been assigned a patent (8,344,076) developed by Stephen M. Dershem, San Diego, for "hydrolytically resistant thermoset monomers." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides hydrolytically resistant monomers prepared by the reaction of an epoxy compound and a reactive ester and methods for producing the monomers. Also provided are adhesive compositions containing the hydrolytically resistant monomers and methods for use thereof." The patent application was filed on Dec. 19, 2007 (11/960,612). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,076&OS=8,344,076&RS=8,344,076 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Homax Products Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Homax Products, Bellingham, Wash., has been assigned a patent (8,344,056) developed by four co-inventors for "aerosol dispensing systems, methods, and compositions for repairing interior structure surfaces." The co-inventors are William Stephen Tait, Madison, Wis., John Kordosh, Simi Valley, Calif., Steve Moore, Acworth, Ga., and Randy Hanson, Bellingham, Wash.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of covering an anomaly in a wall substantially to match a pre-existing texture pattern surrounding the anomaly. The method comprises the following steps. A valve is supported on a container assembly to define a main chamber. Contained material comprising wall material concentrate and propellant material is disposed within the main chamber. An actuator relative is arranged relative to the container assembly such that displacement of a button relative to the valve changes the valve from a closed configuration to an open configuration in which a portion of the propellant material is allowed to force the contained material out of the main chamber through the outlet. A first portion of the contained material is applied to the anomaly by directing the outlet at the anomaly and displacing the button. Optionally, a second portion of the contained material may be applied to the base coat by directing the outlet at the base coat and displacing the button. If applied, the second portion of the contained material forms a desired texture pattern on the base coat that substantially matches the pre-existing texture pattern." The patent application was filed on March 1, 2010 (12/715,228). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,056&OS=8,344,056&RS=8,344,056 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Adds Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Adds Pharmaceuticals, Oakland, Calif., has been assigned a patent (8,343,978) developed by Liang Chang Dong, Sunnyvale, Calif., for "fast onset orodispersable tablets." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides orodispersable tablets and methods of using the same. The tablets and methods are useful, for example, for reducing first pass metabolism of orally administered active agents, enhancing bioavailability of active agents, and/or reducing the time it takes for an active agent to achieve maximal effect in a subject. The tablets, when taken orally, disintegrate or dissolve rapidly such that active agent included in the tablets is absorbed in the buccal cavity. The invention further provides methods of manufacturing any of the tablets disclosed herein and containers that include any of the tablets disclosed herein." The patent application was filed on Dec. 16, 2008 (12/336,463). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,978&OS=8,343,978&RS=8,343,978 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Elevance Renewable Sciences Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Elevance Renewable Sciences, Woodridge, Ill., has been assigned a patent (8,344,052) developed by four co-inventors for "hot melt adhesive compositions comprising metathesized unsaturated polyol ester wax." The co-inventors are Diza Pearl Braksmayer, Chanhassen, Minn., Risha Bond, Mountain View, Calif., William L. Bunnelle, Ham Lake, Minn., and Thomas H. Quinn, St. Paul, Minn.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are hot melt adhesive compositions comprising a metathesized unsaturated polyol ester wax. Typically, the metathesized unsaturated polyol ester wax is derived from renewable starting materials such as vegetable oils or animal fats. The metathesized unsaturated polyol ester wax typically replaces a portion or all of a petroleum-derived wax or synthetic wax in various hot melt adhesive compositions. The hot melt adhesives may be conventional hot melt adhesives or hot melt pressure-sensitive adhesives." The patent application was filed on July 12, 2007 (12/373,016). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,052&OS=8,344,052&RS=8,344,052 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Honeywell International Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Honeywell International, Morristown, N.J., has been assigned a patent (8,344,088) developed by Joseph T. Kennedy, San Jose, Calif., and Teresa Baldwin-Hendricks, Livermore, Calif., for "spin-on anti-reflective coatings for photolithography." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Anti-reflective coating materials for ultraviolet photolithography include at least one absorbing compounds and at least one pH tuning agent that are incorporated into spin-on materials. Suitable absorbing compounds are those that absorb around wavelengths such as 365 nm, 248 nm, 193 nm and 157 nm that may be used in photolithography. Suitable pH tuning agents not only adjust the pH of the final spin-on composition, but also influence the chemical performance and characteristics, mechanical performance and structural makeup of the final spin-on composition that is part of the layered material, electronic component or semiconductor component, such that the final spin-on composition is more compatible with the resist material that is coupled to it. A method of making absorbing and pH tuned spin-on materials includes combining at least one organic absorbing compound and at least one pH tuning agent with at least one silane reactant during synthesis of the spin-on materials and compositions." The patent application was filed on Nov. 15, 2001 (10/495,688). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,088&OS=8,344,088&RS=8,344,088 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** No-Burn Investments Assigned Patent ALEXANDRIA, Va., Jan. 5 -- No-Burn Investments, Wadsworth, Ohio, has been assigned a patent (8,344,055) developed by Michael John Mabey, Sherwood Park, Calif., and William Kish, Wadsworth, Ohio, for an "ammonium phosphate fire retardant with water resistance." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An ammonium phosphate containing fire retardant is combined with a fluoropolymer and/or a penetrating barrier, borate-containing formulation having resistance to water damage with protective properties coming from materials such as used in food packaging and cosmetics and/or a medium-to-long chain polar carboxyl substance, and/or a medium-to-long chain polar carboxyl substance without borate, so as to make a composition. The composition can be aqueous. It can be a liquid of light to moderate viscosity, or may be a concentrated or dried version, which may contain a neutral ammonium phosphate and perhaps other ingredient(s) such as a mold inhibitor, an insecticide, a stain protector, and so forth and the like. The mold inhibitor can have especial activity against toxic black mold (Stachybotrys chartarum). The insecticide may be a termiticide. Such a composition can be made by contacting the fire retardant and other necessary ingredient(s) under conditions sufficient to form the composition; it can be used by contacting it with a substrate, which beneficially is otherwise flammable. A process for incorporation of an ammonium phosphate containing fire retardant into wood includes contacting the wood with a liquid at an effective pH above the pH of the wood, where the liquid embraces a combination in proximity or time of an amine oxide and a buffering agent, as well as the ammonium phosphate containing fire retardant, under conditions such that the ammonium phosphate containing fire retardant is incorporated into the wood. Another aspect is the composition or its residue in combination with the substrate." The patent application was filed on June 29, 2010 (12/803,557). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,055&OS=8,344,055&RS=8,344,055 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Boston Scientific Scimed Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Boston Scientific Scimed, Maple Grove, Minn., has been assigned a patent (8,343,041) developed by eight co-inventors for an "integrated locking device with passive sealing." The co-inventors are Ransom H. Byers, Mountain View, Calif., Alexander E. Dillon, Cambridge, Mass., Thomas C. Kochem, Belmont, Mass., Daniel W. Rice, Gettysburg, Pa., Allison L. Schmidt, Dothan, Ala., Gary A. Jordan, Litchfield, N.H., Douglas Pleskow, Needham, Mass., and Brian Tinkham, South Boston, Mass.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Endoscope assemblies, biopsy caps, and methods for making and using the same. An example endoscope assembly may include an endoscope having a channel formed therein and a port that provides access to the channel. A cap may be coupled to the port. The cap may include a base having a securing member for securing the cap to the port, an outer shell, a locking member coupled to the outer shell, an inner seal member, and a central opening that extends to the channel. The inner seal member may include a plurality of flaps." The patent application was filed on May 18, 2009 (12/467,962). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,041&OS=8,343,041&RS=8,343,041 Written by Neha Bharti; edited by Jaya Anand.

*** Pacesetter Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Pacesetter, Sylmar, Calif., has been assigned a patent (8,343,059) developed by Steve Koh, South Pasadena, Calif., for "identifying left atrial pressure elevation by means of a respiratory component." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A signal indicative of left atrial pressure in the heart of a patient is analyzed to identify a signal component that is related to the respiration of the patient. An indication relating to the left atrial pressure may be generated based on the presence, absence, or magnitude of the respiratory component. In some embodiments the indication may be used to indicate high left atrial pressure. In some embodiments the indication may be used to indicate heart failure. In some embodiments the indication may be used in conjunction with verifying the operation of a left atrial pressure sensor. In the event of high left atrial pressure or an incorrect pressure reading an appropriate warning may be generated. In the event of an incorrect pressure reading the left atrial pressure sensor may be recalibrated." The patent application was filed on Feb. 23, 2007 (11/678,401). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,059&OS=8,343,059&RS=8,343,059 Written by Neha Bharti; edited by Jaya Anand.

*** Abbott Diabetes Care Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Abbott Diabetes Care, Alameda, Calif., has been assigned a patent (8,343,092) developed by Benjamin M. Rush, Oakland, Calif., and Christopher V. Reggiardo, Castro Valley, Calif., for a "method and system for providing integrated medication infusion and analyte monitoring system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Method and system for integrating infusion device and analyte monitoring system including medication infusion device such as an insulin pump and an analyte monitoring system such as a glucose monitoring system are provided." The patent application was filed on Nov. 24, 2009 (12/625,518). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,092&OS=8,343,092&RS=8,343,092 Written by Neha Bharti; edited by Jaya Anand.

*** Senergy Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Senergy, Chadds Ford, Pa., has been assigned a patent (8,344,035) developed by Alfred G. Comolli, Yardley, Pa., and David L. Tanner, Citrus Heights, Calif., for a "tire recycling method generating carbonous reside." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for making a carbonaceous material and a carbonous residue from scrap tires is disclosed. Tires are digested in an oil product. Steel and glass fibers are separated. A product enhancing additive comprising halogen based organic or inorganic compounds is added. The resulting carbonaceous material is then cured to create the final product. The produced carbonous residue is well suited for capture of mercury. The present invention has the benefits of providing a use for scrap tires that would otherwise require disposal in a landfill, and also produces a product useful for capturing a harmful element, thereby providing multiple environmental and economic benefits." The patent application was filed on Sept. 13, 2010 (12/880,829). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,035&OS=8,344,035&RS=8,344,035 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Silk Road Medical Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Silk Road Medical, Palo Alto, Calif., has been assigned a patent (8,343,089) developed by David W. Chang, Cupertino, Calif., for a "method and apparatus for treating a carotid artery." The abstract of the patent published by the U.S. Patent and Trademark Office states: "One disclosed embodiment comprises a method for treating lesions in the carotid artery of a mammalian body. The method comprises transcervical access and blocking of blood flow through the common carotid artery (with or without blocking of blood flow through the external carotid artery), shunting blood from the internal carotid artery and treating the lesion in the carotid artery." The patent application was filed on April 1, 2010 (12/753,027). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,089&OS=8,343,089&RS=8,343,089 Written by Neha Bharti; edited by Jaya Anand.

*** Senorx Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Senorx, Tempe, Ariz., has been assigned a patent (8,343,071) developed by five co-inventors for a "biopsy device with aperture orientation and improved tip." The co-inventors are Martin V. Shabaz, Lake Forest, Calif., Richard L. Quick, Mission Viejo, Calif., Frank R. Louw, Carlsbad, Calif., Paul Lubock, Laguna Niguel, Calif., and Jason H. Safabash, Aliso Viejo, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention is directed to a system and device for separating and collecting a tissue specimen from a target site within a patient. The device includes a probe component which is releasably secured to the driver component. The probe component has an elongated tubular section, a penetrating distal tip and a tissue receiving aperture in the distal end of the tubular section proximal to the distal tip, and a tissue cutting member which is slidably disposed within the probe member to cut a tissue specimen drawn into the interior of the device through the aperture by applying a vacuum to the inner lumen of the tissue cutting member. The driver has drive members for operating the elements of the probe component. The tissue penetrating distal tip preferably has a triple concave curvature shape with three curved cutting edges leading to a sharp distal point." The patent application was filed on Oct. 31, 2007 (11/981,149). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,071&OS=8,343,071&RS=8,343,071 Written by Neha Bharti; edited by Jaya Anand.

*** Integrated Sensing Systems Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Integrated Sensing Systems, Ypsilanti, Mich., has been assigned a patent (8,343,068) developed by four co-inventors for a "sensor unit and procedure for monitoring intracranial physiological properties." The co-inventors are Nader Najafi, Ann Arbor, Mich., Catherine Hook Morgan, Ann Arbor, Mich., David Joseph Goetzinger, Livonia, Mich., and Sonbol Massoud-Ansari, El Dorado Hills, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An anchor for an implantable sensing device, a sensor unit formed by the anchor and sensing device, and a surgical procedure for implanting the sensor unit for monitoring a physiological parameter within a cavity of a living body, such as an intracranial physiological property. The anchor includes a shank portion and a head portion. The shank portion defines a distal end of the anchor and has a bore defining an opening at the distal end. The head portion defines a proximal end of the anchor and has a larger cross-sectional dimension than the shank portion. The sensor unit comprises the anchor and the sensing device placed and secured within the bore of the anchor so that a sensing element of the sensing device is exposed for sensing the physiological parameter within the cavity." The patent application was filed on May 25, 2010 (12/786,685). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,068&OS=8,343,068&RS=8,343,068 Written by Neha Bharti; edited by Jaya Anand.

*** Gilead Sciences Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Gilead Sciences, Foster City, Calif., has been assigned a patent (8,344,018) developed by Michael Graupe, Pacifica, Calif., and Chandrasekar Venkataramani, Redwood City, Calif., for oxindolyl inhibitor compounds.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A compound of general Formula (I) having histone deacetylase (HDAC) and/or CDK inhibitory activity, a pharmaceutical composition comprising the compound, and a method useful to treat diseases using the compound. (Formula should be inserted here) Formula (I) ##STR00001##" The patent application was filed on July 14, 2009 (12/997,487). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,018&OS=8,344,018&RS=8,344,018 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Intuitive Surgical Operations Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Intuitive Surgical Operations, Sunnyvale, Calif., has been assigned a patent (8,343,045) developed by Charles E. Swinehart, San Jose, Calif., and Theodore W. Rogers, Alameda, Calif., for a curved cannula.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The cross section of a curved portion of a curved cannula is oval shaped. The oval is oriented such that a major axis of the oval is generally aligned with the curved portion's bend radius. In one aspect, the cannula tube is ovalized so that the radius of curvature of an interior wall approaches the outer radius of an instrument component that contacts the curved portion during instrument insertion. In this first aspect, a wider contact patch area between the instrument component and the cannula results, which reduces friction and stick-slip during insertion. In another aspect, the cannula tube is ovalized so that the radius of curvature of an interior wall is less than the outer radius of an instrument component that contacts the curved portion during instrument insertion. In this second aspect, two contact patches are established between the instrument component and cannula, which also reduces friction and stick-slip during instrument insertion. Also disclosed is a cannula orientation marking that changes circumferential orientation along a length the curved cannula to help a person who is inserting the cannula to properly twist the cannula during insertion." The patent application was filed on May 14, 2010 (12/780,724). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,045&OS=8,343,045&RS=8,343,045 Written by Neha Bharti; edited by Jaya Anand.

*** NuVasive Assigned Patent ALEXANDRIA, Va., Jan. 5 -- NuVasive, San Diego, has been assigned a patent (8,343,046) developed by eight co-inventors for a "surgical access system and related methods." The co-inventors are Patrick Miles, San Deigo, Scot Martinelli, Mountain Top, Pa., Eric Finley, Poway, Calif., James Gharib, San Diego, Allen Farquhar, Portland, Ore., Norbert Kaula, Arvada, Colo., Jeffrey Blewett, San Diego, and Goretti Medeiros, Plantsville, Conn.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for accessing a spinal disc of a lumbar spine of a patient using a surgical access system including a tissue distraction assembly and a tissue retraction assembly. The method can include maintaining an operative corridor along a lateral, trans-psoas path using the retraction assembly." The patent application was filed on March 12, 2012 (13/417,499). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,046&OS=8,343,046&RS=8,343,046 Written by Neha Bharti; edited by Jaya Anand.

*** Amgen Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Amgen, Thousand Oaks, Calif., has been assigned a patent (8,344,110) developed by Christiaan M. Saris, Newbury Park, Calif., and Ming-Shi Chang, Newbury Park, Calif., for "antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides Thymic Stromal Lymphopoietin Receptor (TSLPR) polypeptides and nucleic acid molecules encoding the same. The invention also provides selective binding agents, vectors, host cells, and methods for producing TSLPR polypeptides. The invention further provides pharmaceutical compositions and methods for the diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with TSLPR polypeptides." The patent application was filed on June 8, 2011 (13/156,106). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,110&OS=8,344,110&RS=8,344,110 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Applied Medical Resources Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Applied Medical Resources, Rancho Santa Margarita, Calif., has been assigned a patent (8,343,047) developed by six co-inventors for a "surgical instrument access device." The co-inventors are Jeremy J. Albrecht, Ladera Ranch, Calif., Juan J. Lechuga, Santa Ana, Calif., Matthew M. Becerra, Foothill Ranch, Calif., Donald K. Gadberry, San Clemente, Calif., Gary M. Johnson, Mission Viejo, Calif., and John R. Brustad, Dana Point, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Embodiments of an access device system useful for single or limited port procedures includes a retractor and a gel cap removably coupled to the retractor. The gel cap includes a gel pad that acts as an artificial body wall, through which instruments may be inserted into a body cavity, either directly or through one or more trocars. The gel pad permits flexible instrument placement, as well as translational and angular degrees of freedom for the instruments while maintaining a gas tight seal." The patent application was filed on Jan. 22, 2009 (12/358,080). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,047&OS=8,343,047&RS=8,343,047 Written by Neha Bharti; edited by Jaya Anand.

*** Case Western Reserve University Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Case Western Reserve University, Cleveland, has been assigned a patent (8,344,116) developed by Young Jik Kwon, Irvine, Calif., for "polymers and complexes for delivery of nucleic acids to intracellular targets." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A complex includes a nucleic acid and a cationic polymer with at least one side chain coupled to the nucleic acid. The at least one side chain including an acid degradable amine-bearing ketal or acetal linkage." The patent application was filed on March 17, 2009 (12/405,313). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,116&OS=8,344,116&RS=8,344,116 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Anacor Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Anacor Pharmaceuticals, Palo Alto, Calif., has been assigned a patent (8,343,944) developed by 12 co-inventors for trisubstituted boron-containing molecules. The co-inventors are Yi Xia, Palo Alto, Calif., Michael Richard Kevin Alley, Santa Clara, Calif., Yasheen Zhou, Moraga, Calif., Rajeshwar Singh, Edmonton, Canada, Charles Ding, San Mateo, Calif., Kathy Cao, Sunnyvale, Calif., Jacob J. Plattner, Orinda, Calif., Ligong Ou, Edmonton, Canada, Guofeng Jia, Edmonton, Canada, Neerja Saraswat, Edmonton, Canada, Sreekanth Ramachandran, Edmonton, Canada, and Ding Zhou, Shanghai, China.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention largely relates to 3,4,6-trisubstituted benzoxaborole compounds, and their use for treating bacterial infections." The patent application was filed on July 27, 2010 (12/844,748). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,944&OS=8,343,944&RS=8,343,944 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Innovative Micro Technology Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Innovative Micro Technology, Goleta, Calif., has been assigned a patent (8,343,791) developed by John S. Foster, Santa Barbara, Calif., John C. Harley, Santa Barbara, Calif., and Jeffery F. Summers, Santa Barbara, Calif., for a "plating process and apparatus for through wafer features." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for forming through features in a substrate uses a seed layer deposited over a first substrate, and a second substrate bonded to the seed layer. The features may be formed in the first substrate, by plating a conductive filler material onto the seed layer. The first substrate and the second substrate may then be bonded to a third substrate, and the second substrate is removed, leaving through features and first substrate adhered to the third substrate. The through features may provide at least one of electrical access and motion to a plurality of devices formed on the third substrate, or may impart movement to a moveable feature on the first substrate, wherein the third substrate supports the first substrate after removal of the second substrate." The patent application was filed on Oct. 5, 2010 (12/923,693). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,791&OS=8,343,791&RS=8,343,791 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Vertex Pharmaceuticals Assigned Patent for Quinazoles Useful as Modulators of Ion Channels ALEXANDRIA, Va., Jan. 5 -- Vertex Pharmaceuticals, Cambridge, Mass., has been assigned a patent (8,343,980) developed by 11 co-inventors for "quinazoles useful as modulators of ion channels." The co-inventors are Jesus Gonzalez III, Carlsbad, Calif., Dean Wilson, Bedford, Mass., Andreas Termin, Encinitas, Calif., Peter D.J. Grootenhuis, San Diego, Yulian Zhang, Yardley, Pa., Benjamin Petzoldt, Bradenton, Fla., Lev T.D. Fanning, San Marcos, Calif., Timothy Neubert, San Diego, Roger Tung, Lexington, Mass., Esther Martinborough, San Diego, and Nicole Hilgraf, San Diego.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels and calcium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders." The patent application was filed on Jan. 15, 2010 (12/688,163). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,980&OS=8,343,980&RS=8,343,980 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Cancer Advances Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Cancer Advances, Durham, N.C., has been assigned a patent (8,343,930) developed by five co-inventors for a "combination therapy for the treatment of tumors." The co-inventors are Philip C. Gevas, Key Biscayne, Fla., Stephen Grimes, Davis, Calif., Stephen L. Karr, Davis, Calif., Susan A. Watson, Nottingham, United Kingdom, and Dov Michaeli, Larkspur, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to a combination therapy method for treating gastrin-dependent tumors. The method comprises the immunization of a patient with an anti-gastrin 17 immunogenic composition in combination with the administration of chemotherapeutic agents such as 5-fluorouracil and leucovorin." The patent application was filed on Jan. 25, 2010 (12/693,127). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,930&OS=8,343,930&RS=8,343,930 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Chevron Oronite Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Chevron Oronite, San Ramon, Calif., has been assigned a patent (8,343,901) developed by Yat Fan Suen, Pinole, Calif., John Ward, San Francisco, and Trevor Miller, Dublin, Calif., for a "lubricating composition containing multifunctional hydroxylated amine salt of a hindered phenolic acid." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Multi-functional additives which impart improved antioxidancy to lubricating oil compositions and frictional properties resulting in improved fuel economy in an internal combustion engine are disclosed. More particularly disclosed are lubricating oil compositions for internal combustion engines comprising a) a major amount of an oil of lubricating viscosity; and b) a minor amount of an oil soluble hydroxylated amine salt of a hindered phenolic acid, said salt having the general formula I: ##STR00001## wherein A and Q are each independently C.sub.2-C.sub.6 alkylene group; R is methyl, alkyl or alkenyl group having C.sub.2-C.sub.24 carbon atoms; Y is hydrogen, C.sub.1-C.sub.6 alkyl group or A-OH; x is an integer of 1 or 2; and z is an integer of 0 or 1." The patent application was filed on Oct. 12, 2010 (12/902,729). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,901&OS=8,343,901&RS=8,343,901 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Optimer Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Optimer Pharmaceuticals, San Diego, has been assigned a patent (8,343,936) developed by four co-inventors for antibacterial agents. The co-inventors are Jonathan Duffield, San Diego, Youe-Kong Shue, Carlsbad, Calif., Yoshitaka Ichikawa, San Diego, and Chan-Kou Hwang, San Diego.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein are novel macrolides, the preparation of novel macrolides, the use of novel macrolides for preventing, treating, or ameliorating various conditions, and the use of novel macrolides as antibacterial agents." The patent application was filed on July 26, 2011 (13/136,172). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,936&OS=8,343,936&RS=8,343,936 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Allergan Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Allergan, Irvine, Calif., has been assigned a patent (8,343,949) developed by Robert T. Lyons, Laguna Hills, Calif., and Robert S. Jordan, Trabuco Canyon, Calif., for "stabilized compositions comprising a therapeutically active agent, and an oxidizing preservative." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Citric acid and conjugate bases thereof are useful for stabilizing stabilized chlorine dioxide in the presence of therapeutically active agents and excipients in a composition. Ophthalmic compositions and methods related thereto are also disclosed herein." The patent application was filed on May 19, 2005 (11/570,200). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,949&OS=8,343,949&RS=8,343,949 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Intermolecular Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Intermolecular, San Jose, Calif., has been assigned a patent (8,343,866) developed by David E. Lazovsky, Los Gatos, Calif., Sandra G. Malhotra, San Jose, Calif., and Thomas R. Boussie, Menlo Park, Calif., for a "formation of a masking layer on a dielectric region to facilitate formation of a capping layer on electrically conductive regions separated by the dielectric region." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A masking layer is formed on a dielectric region of an electronic device so that, during subsequent formation of a capping layer on electrically conductive regions the masking layer inhibits formation of capping layer material on the dielectric region. The capping layer can be formed selectively on the electrically conductive regions or non-selectively; in either case, capping layer material formed over the dielectric region can subsequently be removed, thus ensuring that capping layer material is formed only on the electrically conductive regions. Silane-based materials, such as silane-based SAMs, can be used to form the masking layer. The capping layer can be formed of an electrically conductive, a semiconductor material, or an electrically insulative material, and can be formed using any appropriate process, including conventional deposition processes such as electroless deposition, chemical vapor deposition, physical vapor deposition or atomic layer deposition." The patent application was filed on Oct. 3, 2011 (13/251,952). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,866&OS=8,343,866&RS=8,343,866 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Theravance Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Theravance, South San Francisco, Calif., has been assigned a patent (8,344,013) developed by eight co-inventors for "dual-acting imidazole antihypertensive agents." The co-inventors are Paul Allegretti, Fort Collins, Colo., Seok-Ki Choi, Ann Arbor, Mich., Roland Gendron, San Francisco, Paul R. Fatheree, San Francisco, Keith Jendza, Boston, Robert Murray McKinnell, Millbrae, Calif., Darren McMurtrie, Foster City, Calif., and Brooke Olson, San Francisco.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention is directed to compounds having the formula: ##STR00001## wherein: Ar, r, R.sup.2-3, X, and R.sup.5-7 are as defined in the specification, and pharmaceutically acceptable salts thereof. These compounds have AT.sub.1 receptor antagonist activity and neprilysin inhibition activity. The invention is also directed to pharmaceutical compositions comprising such compounds; methods of using such compounds; and process and intermediates for preparing such compounds." The patent application was filed on March 6, 2012 (13/413,076). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,013&OS=8,344,013&RS=8,344,013 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** University of California Assigned Patent ALEXANDRIA, Va., Jan. 5 -- The University of California, Oakland, Calif., has been assigned a patent (8,344,042) developed by four co-inventors for "biodegradable synthetic bone composites." The co-inventors are Gao Liu, Oakland, Calif., Dacheng Zhao, Shenzhen, China, Eduardo Saiz, London, and Antoni P. Tomsia, Pinole, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides for a biodegradable synthetic bone composition comprising a biodegradable hydrogel polymer scaffold comprising a plurality of hydrolytically unstable linkages, and an inorganic component; such as a biodegradable poly(hydroxyethylmethacrylate)/hydroxyapatite (pHEMA/HA) hydrogel composite possessing mineral content approximately that of human bone." The patent application was filed on Dec. 8, 2009 (12/633,708). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,042&OS=8,344,042&RS=8,344,042 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Rigel Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Rigel Pharmaceuticals, South San Francisco, Calif., has been assigned a patent (8,343,954) developed by eight co-inventors for "compositions and methods for inhibition of the JAK pathway." The co-inventors are Hui Li, Santa Clara, Calif., Thilo J. Heckrodt, San Francisco, Calif., Yan Chen, Foster City, Calif., Darren John McMurtrie, Foster City, Calif., Vanessa Taylor, San Francisco, Rajinder Singh, Belmont, Calif., Pingyu Ding, Foster City, Calif., and Rose Yen, San Francisco.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful. Also disclosed are methods of making the compounds." The patent application was filed on July 27, 2011 (13/192,344). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,954&OS=8,343,954&RS=8,343,954 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Luo, Ling Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Yuhao Luo, San Jose, Calif., and Zhi-min Ling, Cupertino, Calif., have been assigned a patent (8,343,795) developed by Yuhao Luo, and Zhi-min Ling, for a "method to break and assemble solar cells." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present disclosure relates generally to a method to break and assemble solar cells to make solar panel. The present disclosure provides a method to produce solar pieces from solar cell, as well as assemble them together. The present disclosure device is unique when compared with other known devices and solutions because the present disclosure provides a high speed method to break scribed cells into pieces. A method of forming a string of solar cells includes providing a scribe line on a solar cell and placing a first ribbon on the solar cell. The method then includes placing the solar cell on a supporter and then breaking the solar cell into a plurality of solar cell pieces. The method then has the step of placing a second ribbon on the solar cell pieces and soldering the first and second ribbons and the solar cell pieces and then assembling the solar cell pieces into a string of solar cells." The patent application was filed on Sept. 8, 2010 (12/877,953). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,795&OS=8,343,795&RS=8,343,795 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Bristol-Myers Squibb Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,343,999) developed by eight co-inventors for "thiazolyl compounds useful as kinase inhibitors." The co-inventors are Anne Marinier, Kirkland, Calif., Marco Dodier, Wotton, Calif., Stephan Roy, Levis, Calif., Kurt Zimmermann, Durham, Conn., Xiaopeng Sang, Glastonbury, Conn., Mark D. Wittman, Wallingford, Conn., David R. Langley, Meriden, Conn., and Ramkumar Rajamani, Middletown, Conn.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides compounds of formula I ##STR00001## and pharmaceutically acceptable salts thereof. The formula I thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's disease." The patent application was filed on April 9, 2008 (12/595,065). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,999&OS=8,343,999&RS=8,343,999 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** XenoPort Assigned Patent ALEXANDRIA, Va., Jan. 5 -- XenoPort, Santa Clara, Calif., has been assigned a patent (8,344,028) developed by five co-inventors for "gamma-amino-butyric acid derivatives as GABA.sub.B receptor ligands." The co-inventors are Feng Xu, Palo Alto, Calif., Mark A. Gallop, Santa Clara, Calif., Ge Peng, Mountain View, Calif., Thu Phan, Fremont, Calif., Usha Dilip, Sunnyvale, Calif., and David J. Wustrow, Saratoga, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Gamma-amino-butyric acid derivatives that are GABA.sub.B receptor ligands, pharmaceutical compositions comprising such derivatives, and methods of using such derivatives and pharmaceutical compositions thereof for treating diseases are disclosed." The patent application was filed on April 16, 2010 (12/762,152). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,344,028&OS=8,344,028&RS=8,344,028 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Genentech Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Genentech, South San Francisco, Calif., has been assigned a patent (8,343,955) developed by 13 co-inventors for a "benzoxazepin PI3K inhibitor compounds and methods of use." The co-inventors are Nicole Blaquiere, South San Francisco, Calif., Steven Do, South San Francisco, Calif., Danette Dudley, South San Francisco, Calif., Adrian Folkes, Basel, Switzerland, Robert Heald, Harlow, United Kingdom, Timothy Heffron, South San Francisco, Calif., Mark Jones, Harlow, United Kingdom, Aleksandr Kolesnikov, South San Francisco, Calif., Chudi Ndubaku, South San Francisco, Calif., Alan G. Olivero, South San Francisco, Calif., Stephen Price, Harlow, United Kingdom, Steven Staben, South San Francisco, Calif., and Lan Wang, South San Francisco, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Benzoxazepin compounds of Formula I, including stereoisomers, geometric isomers, tautomers, solvates, metabolites and pharmaceutically acceptable salts thereof, wherein: Z.sup.1 is CR.sup.1 or N; Z.sup.2 is CR.sup.2 or N; Z.sup.3 is CR.sup.3 or N; Z.sup.4 is CR.sup.4 or N; and B is a pyrazolyl, imidazolyl, or triazolyl ring fused to the benzoxepin ring, are useful for inhibiting lipid kinases including p110 alpha and other isoforms of PI3K, and for treating disorders such as cancer mediated by lipid kinases. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed. ##STR00001##." The patent application was filed on May 22, 2012 (13/477,587). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,955&OS=8,343,955&RS=8,343,955 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Applied Materials Assigned Patent for Silicon Dioxide Layer Deposited with BDEAS ALEXANDRIA, Va., Jan. 5 -- Applied Materials, Santa Clara, Calif., has been assigned a patent (8,343,881) developed by 10 co-inventors for a "silicon dioxide layer deposited with BDEAS." The co-inventors are Yong-Won Lee, San Jose, Calif., Vladimir Zubkov, Mountain View, Calif., Mei-Yee Shek, Palo Alto, Calif., Li-Qun Xia, Cupertino, Calif., Prahallad Iyengar, Mountain View, Calif., Sanjeev Baluja, Campbell, Calif., Scott A. Hendrickson, Brentwood, Calif., Juan Carlos Rocha-Alvarez, San Carlos, Calif., Thomas Nowak, Cupertino, Calif., and Derek R. Witty, Fremont, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A silicon dioxide layer is deposited onto a substrate using a process gas comprising BDEAS and an oxygen-containing gas such as ozone. The silicon dioxide layer can be part of an etch-resistant stack that includes a resist layer. In another version, the silicon dioxide layer is deposited into through holes to form an oxide liner for through-silicon vias." The patent application was filed on June 4, 2010 (12/794,713). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,881&OS=8,343,881&RS=8,343,881 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Lam Research Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Lam Research, Fremont, Calif., has been assigned a patent (8,343,876) developed by five co-inventors for a "fast gas switching plasma processing apparatus." The co-inventors are S.M. Reza Sadjadi, Saratoga, Calif., Zhisong Huang, Fremont, Calif., Jose Tong Sam, Fremont, Calif., Eric H. Lenz, Pleasanton, Calif., and Rajinder Dhindsa, San Jose, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A plasma chamber with a plasma confinement zone with an electrode is provided. A gas distribution system for providing a first gas and a second gas is connected to the plasma chamber, wherein the gas distribution system can substantially replace one gas in the plasma zone with the other gas within a period of less than 1 s. A first frequency tuned RF power source for providing power to the electrode in a first frequency range is electrically connected to the at least one electrode wherein the first frequency tuned RF power source is able to minimize a reflected RF power. A second frequency tuned RF power source for providing power to the plasma chamber in a second frequency range outside of the first frequency range wherein the second frequency tuned RF power source is able to minimize a reflected RF power." The patent application was filed on July 22, 2011 (13/189,416). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,876&OS=8,343,876&RS=8,343,876 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Chevron USA Assigned Patent for Hydroconversion Processes Employing Multi-metallic Catalysts and Method for Making ALEXANDRIA, Va., Jan. 5 -- Chevron USA, San Ramon, Calif., has been assigned a patent (8,343,887) developed by Theodorus Ludovicus Michael Maesen, Richmond, Calif., and Alexander E. Kuperman, Orinda, Calif., for "hydroconversion processes employing multi-metallic catalysts and method for making thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A catalyst precursor composition and methods for making such catalyst precursor is disclosed. In one embodiment, the catalyst precursor is of the general formula A.sub.v[(M.sup.P)(OH).sub.x(L).sup.n.sub.y].sub.z(M.sup.VIBO.sub.4), wherein M.sup.P is selected from Group VIII, Group IIB, Group IIA, Group IVA and combinations thereof; L is one or more oxygen-containing ligands, and L has a neutral or negative charge n<=0, M.sup.VIB is at least a Group VIB metal having an oxidation state of +6; M.sup.P:M.sup.VIB has an atomic ratio between 100:1 and 1:100; v-2+P*z-x*z+n*y*z=0; and 0.ltoreq.y.ltoreq.-P/n; 0.ltoreq.x.ltoreq.P; 0.ltoreq.v.ltoreq.2; 0.ltoreq.z. In one embodiment, the catalyst precursor further comprises a cellulose-containing material. In another embodiment, the catalyst precursor further comprises at least a diluent (binder). In one embodiment, the diluent is a magnesium aluminosilicate clay." The patent application was filed on Oct. 28, 2008 (12/259,451). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,887&OS=8,343,887&RS=8,343,887 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Fairchild Semiconductor Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Fairchild Semiconductor, South Portland, Maine, has been assigned a patent (8,343,852) developed by seven co-inventors for a "method and structure for dividing a substrate into individual devices." The co-inventors are Minhua Li, Sandy, Utah, Qi Wang, Sandy, Utah, Gordon Sim, Sandy, Utah, Matthew Reynolds, Sandy, Utah, Suku Kim, South Jordan, Utah, James J. Murphy, South Jordan, Utah, and Hamza Yilmaz, Saratoga, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for obtaining individual dies from a semiconductor structure is disclosed. The semiconductor structure includes a device layer, and the device layer in turn includes active regions separated by predefined spacings. Thick metal is selectively formed on backside of the device layer such that thick metal is formed on backside of active regions but not on backside of the predefined spacings. The semiconductor structure is then cut along the predefined spacings to separate the active regions with thick metal on their backside into individual dies." The patent application was filed on April 27, 2011 (13/095,584). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,852&OS=8,343,852&RS=8,343,852 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Intermolecular Assigned Patent for Resistive-switching Memory Elements Having Improved Switching Characteristics ALEXANDRIA, Va., Jan. 5 -- Intermolecular, San Jose, Calif., has been assigned a patent (8,343,813) developed by Ronald John Kuse, Dublin, Calif., Imran Hashim, Saratoga, Calif., and Tony Chiang, Campbell, Calif., for a "resistive-switching memory elements having improved switching characteristics." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Resistive-switching memory elements having improved switching characteristics are described, including a memory element having a first electrode and a second electrode, a switching layer between the first electrode and the second electrode comprising hafnium oxide and having a first thickness, and a coupling layer between the switching layer and the second electrode, the coupling layer comprising a material including metal titanium and having a second thickness that is less than 25 percent of the first thickness." The patent application was filed on Feb. 12, 2010 (12/705,474). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,343,813&OS=8,343,813&RS=8,343,813 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** O2Micro Assigned Patent for Circuits and Methods for Controlling a Charge Pump System ALEXANDRIA, Va., Jan. 5 -- O2Micro, Santa Clara, Calif., has been assigned a patent (8,344,790) developed by Guoxing Li, Sunnyvale, Calif., for "circuits and methods for controlling a charge pump system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A circuit includes a charge pump and a feedback circuit. The charge pump coupled to a switch provides a control signal to the switch. The feedback circuit coupled to the charge pump receives the control signal and adjusts an operating frequency of the charge pump based upon the control voltage. The control voltage is adjusted to a predetermined target voltage by adjusting the operating frequency through the feedback circuit." The patent application was filed on Dec. 20, 2010 (12/973,574). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,790.PN.&OS=PN/8,344,790&RS=PN/8,344,790 Written by Kusum Sangma; edited by Anand Kumar.

*** Neology Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Neology, Poway, Calif., has been assigned a patent (8,344,890) developed by four co-inventors for "systems and methods for a RFID enabled metal license plate." The co-inventors are Jeffrey Zhu, Carlsbad, Calif., Chih-chuan Yen, San Diego, Jun Liu, San Diego, and Joe Mullis, Oceanside, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "In the embodiments described herein, a RFID enabled license plate is constructed by using the license plate, or a retro-reflective layer formed thereon as part of the resonator configured to transmit signals generated by and RFID chip integrated with the license plate. Such an RFID enabled license plate can include a metal license plate with a slot formed in the metal license plate, and a RFID tag module positioned in the slot. The RFID tag module can include a chip and a loop, and the loop can be coupled with the metal license plate, e.g., via inductive or conductive coupling. In this manner, the metal license plate can be configured to act as a resonator providing increased performance." The patent application was filed on Dec. 20, 2007 (11/962,047). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,890.PN.&OS=PN/8,344,890&RS=PN/8,344,890 Written by Kusum Sangma; edited by Anand Kumar.

*** Health Hero Network Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Health Hero Network, Palo Alto, Calif., has been assigned a patent (8,344,876) developed by Stephen J. Brown, Woodside, Calif., for a "remote motion monitoring system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system, apparatus, and method for motion monitoring. In an embodiment, a plurality of self-powered active Radio Frequency Identification (RFID) transmitters are each configured to intermittently transmit radio frequency pulse at a rate proportional to motion, containing identification information. The pulse produced by each of the RFID transmitters are received and analyzed at a receiver. The analysis results in the identification of pattern of activity, which is used to produce meaningful data regarding the motion of a user. The RFID transmitters may be provided on a wearable tag." The patent application was filed on March 13, 2008 (12/047,397). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,876.PN.&OS=PN/8,344,876&RS=PN/8,344,876 Written by Kusum Sangma; edited by Anand Kumar.

*** Conexant Systems Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Conexant Systems, Newport Beach, Calif., has been assigned a patent (8,344,797) developed by Lorenzo Crespi, Costa Mesa, Calif., and Christian Larsen, Irvine, Calif., for "systems and methods for offset cancellation method for DC-coupled audio drivers." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Direct current (DC) offset in and audio driver can cause a constant drain on power even when there is no sound. Furthermore it can cause an audible pop when the audio driver is enabled. A scaled replica output stage can be employed to perform DC offset cancellation offline during a sampling phase. Once DC offset cancellation is achieved, the audio driver uses a full scale output stage during the operation phase." The patent application was filed on Nov. 20, 2009 (12/623,202). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,797.PN.&OS=PN/8,344,797&RS=PN/8,344,797 Written by Kusum Sangma; edited by Anand Kumar.

*** Novozymes Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Novozymes, Davis, Calif., has been assigned a patent (8,343,767) developed by Paul Harris, Carnation, Wash., and Howard Brody, Davis, Calif., for "methods for increasing homologous recombination of a nucleic acid sequences." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to methods for increasing homologous recombination of a nucleic acid sequence introduced into a host cell, comprising: (a) introducing into a population of filamentous fungal host cells a first nucleic acid sequence encoding a recombination protein and a second nucleic acid sequence comprising one or more regions which are homologous with the genome of the filamentous fungal host cell, wherein (i) the recombination protein promotes the recombination of the one or more regions with the corresponding homologous region in the host's genome to incorporate the second nucleic acid sequence by homologous recombination, and (ii) the number of host cells comprising the incorporated second nucleic acid sequence in the population is increased at least 20% compared to the same population without the first nucleic acid sequence; (b) and isolating from the population a filamentous fungal cell comprising the incorporated second nucleic acid sequence." The patent application was filed on March 29, 2012 (13/434,694). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,343,767.PN.&OS=PN/8,343,767&RS=PN/8,343,767 Written by Kusum Sangma; edited by Anand Kumar.

*** Raytheon Assigned Patent for System and Method for Resolving Ambiguity in Radar, Lidar, and Acoustic Systems ALEXANDRIA, Va., Jan. 5 -- Raytheon, Waltham, Mass., has been assigned a patent (8,344,942) developed by Michael Yih-Hwa Jin, San Gabriel, Calif., and Chi-Yung Chang, Torrance, Calif., for a "system and method for resolving ambiguity in radar, lidar, and acoustic systems." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Range and Doppler ambiguities are common in radar, lidar, and acoustic systems. Resolving these ambiguities is important to achieve desirable geolocation and image quality performance in these systems. A new method is described to iteratively resolve the ambiguities. For Doppler ambiguity applications, a first PRF value and an initial Doppler frequency search window are selected. A new PRF is determined based on the ratio of the initial search window to the first PRF. The radar data of the first pair of PRF's is used to determine two modulo Doppler estimates. The modulo Doppler estimates are used to determine a new Doppler estimate with a confidence interval smaller than the first search window. The ratio of the new Doppler search window to the first PRF, is used to determine the next PRF. This process is iterated until the new Doppler search window is less than the first PRF." The patent application was filed on April 29, 2010 (12/769,814). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,344,942.PN.&OS=PN/8,344,942&RS=PN/8,344,942 Written by Kusum Sangma; edited by Anand Kumar.

*** Apple Assigned Patent ALEXANDRIA, Va., Jan. 5 -- Apple, Cupertino, Calif., has been assigned a patent (8,344,874) developed by Anthony Fadell, Portola Valley, Calif., for an "intelligent power-enabled communications port." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A port that supplies power in accordance with a standard For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1110039 (c) 2013 Targeted News Service

[ Back To Technology News's Homepage ]